| 000 | 00778nam a22002417a 4500 | ||
|---|---|---|---|
| 003 | AM-YeNLA | ||
| 005 | 20240816161714.0 | ||
| 008 | 240710s2018 xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9789811304958 | ||
| 040 |
_aSMU _beng _dSMU |
||
| 041 | 0 | _aeng | |
| 080 | _a616.097 | ||
| 245 | 0 | 0 |
_aDevelopment of Antibody-Based Therapeutics : _bTranslational Considerations & Challenges / _cEditors: Mohammad A. Tabrizi, Gadi G. Bornstein, Scott L. Klakamp . |
| 250 | _a2nd edition. | ||
| 260 |
_aSingapore : _bAdis, _c2018 . |
||
| 300 |
_a250 p. : _bfig., table ; _c23,5 cm. |
||
| 650 | 1 | 4 | _aAntibody-Based Therapeutics |
| 700 | 1 |
_aTabrizi, Mohammad A. _eedt |
|
| 700 | 1 |
_aBornstein, Gadi G. _eedt |
|
| 700 | 1 |
_aKlakamp, Scott L. _eedt |
|
| 942 |
_2udc _cBK |
||
| 998 | _cSMUAno_2 | ||
| 999 |
_c1960152 _d1960130 |
||